Cargando…
Enhancement of Apx Toxin Production in Actinobacillus pleuropneumoniae Serotypes 1, 2, and 5 by Optimizing Culture Conditions
Actinobacillus pleuropneumoniae (APP) is a causative agent of porcine pleuropneumonia. Therefore, the development of an effective vaccine for APP is necessary. Here, we optimized the culture medium and conditions to enhance the production yields of Apx toxins in APP serotype 1, 2, and 5 cultures. Th...
Autores principales: | Dao, Hoai Thu, Do, Van Tan, Truong, Quang Lam, Hahn, Tae-Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Microbiology and Biotechnology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745662/ https://www.ncbi.nlm.nih.gov/pubmed/32238774 http://dx.doi.org/10.4014/jmb.1912.12042 |
Ejemplares similares
-
Construction and immunization with double mutant ΔapxIBD Δpnp forms of Actinobacillus pleuropneumoniae serotypes 1 and 5
por: Dao, Hoai Thu, et al.
Publicado: (2020) -
Cytoplasmic glycoengineering of Apx toxin fragments in the development of Actinobacillus pleuropneumoniae glycoconjugate vaccines
por: Passmore, Ian J., et al.
Publicado: (2019) -
Elucidating the role of ApxI in hemolysis and cellular damage by using a novel apxIA mutant of Actinobacillus pleuropneumoniae serotype 10
por: Chang, Nai-Yun, et al.
Publicado: (2014) -
Development of Actinobacillus pleuropneumoniae ApxI, ApxII, and ApxIII-specific ELISA methods for evaluation of vaccine efficiency
por: Jung, Myunghwan, et al.
Publicado: (2019) -
Probing of Actinobacillus pleuropneumoniae ApxIIIA toxin-dependent cytotoxicity towards mammalian peripheral blood mononucleated cells
por: Vanden Bergh, Philippe GAC, et al.
Publicado: (2008)